Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseases
Autophagy is a lysosome-based degradative process used to recycle obsolete cellular
constituents and eliminate damaged organelles and aggregate-prone proteins. Their …
constituents and eliminate damaged organelles and aggregate-prone proteins. Their …
Mechanisms of Aβ clearance and degradation by glial cells
M Ries, M Sastre - Frontiers in aging neuroscience, 2016 - frontiersin.org
Glial cells have a variety of functions in the brain, ranging from immune defense against
external and endogenous hazardous stimuli, regulation of synaptic formation, calcium …
external and endogenous hazardous stimuli, regulation of synaptic formation, calcium …
Learning interpretable cellular and gene signature embeddings from single-cell transcriptomic data
The advent of single-cell RNA sequencing (scRNA-seq) technologies has revolutionized
transcriptomic studies. However, large-scale integrative analysis of scRNA-seq data remains …
transcriptomic studies. However, large-scale integrative analysis of scRNA-seq data remains …
[HTML][HTML] Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
MMJ Van den Berg, J Krauskopf, JG Ramaekers… - Progress in …, 2020 - Elsevier
Circulating microRNAs (cimiRNAs) are a class of non-encoding RNAs found in bodily fluids
such as blood, cerebrospinal fluid (CSF) and tears. CimiRNAs have been implicated as …
such as blood, cerebrospinal fluid (CSF) and tears. CimiRNAs have been implicated as …
[HTML][HTML] Amyloid precursor protein and endosomal–lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease
RA Nixon - The FASEB Journal, 2017 - ncbi.nlm.nih.gov
Abnormalities of the endosomal–lysosomal network (ELN) are a signature feature of
Alzheimer's disease (AD). These include the earliest known cytopathology that is specific to …
Alzheimer's disease (AD). These include the earliest known cytopathology that is specific to …
Targeting the β secretase BACE1 for Alzheimer's disease therapy
R Yan, R Vassar - The Lancet Neurology, 2014 - thelancet.com
The β secretase, widely known as β-site amyloid precursor protein cleaving enzyme 1
(BACE1), initiates the production of the toxic amyloid β (Aβ) that plays a crucial early part in …
(BACE1), initiates the production of the toxic amyloid β (Aβ) that plays a crucial early part in …
GSK-3β, a pivotal kinase in Alzheimer disease
Alzheimer disease (AD) is the most common form of age-related dementia. The etiology of
AD is considered to be multifactorial as only a negligible percentage of cases have a familial …
AD is considered to be multifactorial as only a negligible percentage of cases have a familial …
Amyloid precursor protein processing and Alzheimer's disease
RJ O'brien, PC Wong - Annual review of neuroscience, 2011 - annualreviews.org
Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the
accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated …
accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated …
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease
R Vassar - Alzheimer's research & therapy, 2014 - Springer
Abstract β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the β-secretase
enzyme required for the production of the neurotoxic β-amyloid (Aβ) peptide that is widely …
enzyme required for the production of the neurotoxic β-amyloid (Aβ) peptide that is widely …
Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques
Through a comprehensive analysis of organellar markers in mouse models of Alzheimer's
disease, we document a massive accumulation of lysosome-like organelles at amyloid …
disease, we document a massive accumulation of lysosome-like organelles at amyloid …